These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2154790)

  • 21. Kappa antagonist effects of buprenorphine in the rat drug-discrimination procedure.
    Negus SS; Picker MJ; Dykstra LA
    NIDA Res Monogr; 1989; 95():518-9. PubMed ID: 2561845
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
    Machelska H; Labuz D; Przewłocki R; Przewłocka B
    J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Influence of dopamine on pars reticulata neurones of substantia nigra (author's transl)].
    Ruffieux A; Schultz W
    J Physiol (Paris); 1981 Apr; 77(1):63-9. PubMed ID: 7230051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of U50,488H on locomotor activity in the hamster.
    Schnur P; Walker JM
    Pharmacol Biochem Behav; 1990 Aug; 36(4):813-6. PubMed ID: 2170998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GABAergic mechanisms in regulating the activity state of substantia nigra pars reticulata neurons.
    Windels F; Kiyatkin EA
    Neuroscience; 2006 Jul; 140(4):1289-99. PubMed ID: 16713116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN; Gulati A; Ramarao P
    J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of a selective kappa receptor agonist, U-50, 488H, on methamphetamine-elicited ipsilateral circling behavior in rats with unilateral nigral lesions.
    Ohno M; Yamamoto T; Ueki S
    Psychopharmacology (Berl); 1989; 97(2):219-21. PubMed ID: 2543013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of microiontophoretically applied U-50488 on the spontaneous discharges, of respiration related units (RRUs) in the region of nucleus ambiguus or rat].
    Zhu GY; Lin FS; Wang CQ
    Sheng Li Xue Bao; 1991 Apr; 43(2):199-203. PubMed ID: 1648794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological analysis of kappa opiate receptor activation in the rabbit vas deferens.
    Lacey MG; Henderson G
    Neuropeptides; 1984 Dec; 5(1-3):257-60. PubMed ID: 6152325
    [No Abstract]   [Full Text] [Related]  

  • 31. Kappa agonists and vasopressin secretion.
    Hamon G; Jouquey S
    Horm Res; 1990; 34(3-4):129-32. PubMed ID: 1966562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid involvement in epileptogenic and neurovisceral activity.
    Pinsky C; Bose R; Hall A; Glavin GB
    Prog Clin Biol Res; 1990; 328():421-4. PubMed ID: 2154802
    [No Abstract]   [Full Text] [Related]  

  • 33. In situ hybridization study of kappa-opioid receptor mRNA in the rat brain.
    Minami M; Hosoi Y; Toya T; Katao Y; Maekawa K; Katsumata S; Yabuuchi K; Onogi T; Satoh M
    Neurosci Lett; 1993 Nov; 162(1-2):161-4. PubMed ID: 7907172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paradoxical locomotor activating effects of kappa-opioid receptor stimulation in the preweanling rat: role of the ventromedial thalamus and superior colliculus.
    Zavala AR; Yoshida ST; Osburn JR; McDougall SA
    Brain Res Dev Brain Res; 2002 Dec; 139(2):301-6. PubMed ID: 12480145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of kappa opiate receptors in intestinal wall affects stress-induced increase of plasma cortisol in dogs.
    Gué M; Alvinerie M; Junien JL; Buéno L
    Brain Res; 1989 Nov; 502(1):143-8. PubMed ID: 2555024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of agonists, inverse agonists, and antagonists of benzodiazepine receptors on the firing rate of substantia nigra pars reticulata neurons.
    Mereu G; Biggio G
    Adv Biochem Psychopharmacol; 1983; 38():201-9. PubMed ID: 6322538
    [No Abstract]   [Full Text] [Related]  

  • 37. Characterization of substantia nigra pars reticulata neurons based on response to iontophoretically applied GABA and flurazepam.
    Zhang H; Weng X; Rosenberg HC
    Life Sci; 1993; 53(25):1911-9. PubMed ID: 8255152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that opioid receptors in the substantia nigra pars reticulata are relevant in regulating the function of striatal efferent pathways.
    Turski L; Havemann U; Kuschinsky K
    Behav Brain Res; 1982 Aug; 5(4):415-22. PubMed ID: 6289848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronal activity of the substantia nigra (pars compacta) after injection of kainic acid into the caudate nucleus.
    Nakamura S; Iwatsubo K; Tsai CT; Iwama K
    Exp Neurol; 1979 Dec; 66(3):682-91. PubMed ID: 488246
    [No Abstract]   [Full Text] [Related]  

  • 40. Substance P as a transmitter candidate.
    Nicoll RA; Schenker C; Leeman SE
    Annu Rev Neurosci; 1980; 3():227-68. PubMed ID: 6158283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.